Leptospirosis during the COVID-19 pandemic: a case report
DOI:
https://doi.org/10.1590/S1678-9946202365018Palabras clave:
Leptospirosis, COVID-19, Plasmapheresis, ARDS, HyperbilirubinemiaResumen
ms. Leptospirosis is one of the most common zoonoses in the world, yet it is mainly a disease of differential diagnosis for places that do not have it as an endemic. Due to the high burden of COVID-19 on the healthcare field, patients suffering from other infections may have been inadvertently neglected. COVID-19 infection can mimic other infectious diseases and can confuse physicians in their search for a confirmatory diagnosis. Nonetheless, it is very crucial to broaden the differential diagnosis and keep diseases like leptospirosis within the differential diagnosis despite its rarity, especially in patients presenting with unexplained systemic infectious symptoms. This is a unique case of a patient who presented with dyspnea, jaundice and change in urine color who was suspected to be COVID-19 positive. After a detailed investigation, the patient was diagnosed with leptospirosis instead of COVID-19 and was treated with plasmapheresis and antibiotics accordingly.
Descargas
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2023 Mehmet Emir Arman, Mustafa Yavuz, Deniz Cekic, Kubilay Issever, Ahmed Cihad Genc, Selcuk Yaylacı
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.